Diaz Paul J
DIAZ PAUL J, DIR, reported a transaction classified as grant at Merck Co., Inc. involving 613.073000 shares for an estimated $91666.67. Reported holdings after the transaction were 613.073000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Nov 01, 2026
- Filing date
- Nov 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MRK price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0000310158-26-000245 Phantom Stock
- Transaction date
- Nov 01, 2026 Filed Nov 03, 2026, 09:41 PM · 2d delay
- Shares
- 613.073 sh $149.52 per share
- Estimated value
- $91.6k Computed from shares × price
- Holdings after
- 613.073 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
1-for-1
- F2
Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Paym…
- F3
The price reported is the closing price of Merck Common Stock on the business day immediately prior to the effective date of the Director's service.
0 other transactions
0 recent txs